Epipens Case Study

843 Words2 Pages

Discussion Post #4 1.Socialize the EpiPen Summary: This article talks about EpiPens but also emphasizes the dysfunction of the American pharmaceutical system. One of the main problems specified in the article was the enormous price increase of EpiPens. Between 2007 and 2016 the price for a set of two EpiPens went from $100 to $600(Jacobin, Sept. 2, 2016). The company that sells the EpiPens is Mylan Pharmaceuticals, however they outsource to Pfizer’s Meridian Medical Technologies, which manufactures a whole lineup of autoinjector products(Jacobin, Sept. 2, 2016). And due to the sky high prices for EpiPens the CEO of Mylan Pharmaceuticals, Heather Bresch, had a huge salary increase from $2.5 million to $18.9 million(Jacobin, Sept. 2, 2016). Not to mention, the development of an autoinjector was sponsored by the Pentagon as a medical advancement whose early development was publicly funded, only to later serve as a source of enormous private profit(Jacobin, Sept. 2, 2016). This article also talks about finding cheaper alternatives, such as generic versions of EpiPens instead of buying the traditional brand. The We deserve so much more than putting other non-important issues in front of our health issues. Companies like Big Pharma and Cigna turn everything into an object for sale and big profit regardless of the rules and guidelines that are supposed to keep them in check. In addition, it was not surprising that during Obama’s presidency he created his own form of universal health care that was a total flop because it is was merely a profit for the government. It sickens me to understand that people make money off of hard working Americans that just want insurance to cover their health needs and that the government doesn’t understand or just doesn’t want to help because they too get a large profit out of our

Open Document